Medical Device Labeling & Information Services
Get expert support for compliant medical device labels, IFUs, and market-specific information requirements across FDA, EU MDR, TGA, and other global frameworks. Elexes helps manufacturers reduce review delays, align claims with regulatory expectations, and build labeling documentation that supports smoother submissions, audits, and post-market compliance.
Our Medical Device Labeling & Information Services
Targeted support for compliant labels, IFUs, submission documentation, and global market information requirements.
Labeling Review
Comprehensive review of device labels, packaging text, and mandatory statements against applicable regulatory requirements to identify gaps, unsupported claims, and missing content before submission or market release.
IFU Compliance
Detailed assessment and refinement of Instructions for Use to improve clarity, consistency, and compliance with FDA, EU MDR, TGA, and other market-specific content expectations.
TGA Labeling
Australian labeling compliance support covering Schedule 1 expectations, TGO 91 considerations, UDI obligations, and alignment of labels and IFUs for ARTG-related submissions.
EU MDR Labeling
Support for EU MDR Annex I Section 23 labeling and IFU requirements, including symbol usage, language planning, mandatory content, and technical file consistency.
510(k) Labeling Review
FDA-focused labeling and IFU review for 510(k) submissions to ensure intended use alignment, required statements, UDI considerations, and consistency with cleared claims.
Global Label Strategy
Cross-market labeling strategy that helps manufacturers harmonize core content while adapting labels and information sets for FDA, TGA, EU MDR, and other jurisdictions.
Global Compliance Support
Clearer Labeling, Stronger Regulatory Readiness
Medical device labeling is more than artwork and packaging text—it is regulated evidence that must align with your intended use, risk profile, technical documentation, and market pathway. Elexes helps manufacturers build compliant labels, IFUs, and information sets that reduce deficiency risk, support smoother authority review, and stay consistent across FDA, EU MDR, TGA, Health Canada, and other global frameworks.
Trusted By Manufacturers
Success Stories
See how manufacturers improve submission quality and labeling compliance with expert regulatory support.
“Excellent communication, diligent work. There is a strong quality background and QMS norms expertise.”
Samip Shah
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Highly recommend Elexes! They always meet commitments and follow through on action items.”
Joshua Mink
“Prompt and competent! Elexes should be your next regulatory consultant. Their timeline-based project plan expedited the process.”
Diane Bryant
“Excellent communication, diligent work. There is a strong quality background and QMS norms expertise.”
Samip Shah
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Highly recommend Elexes! They always meet commitments and follow through on action items.”
Joshua Mink
“Prompt and competent! Elexes should be your next regulatory consultant. Their timeline-based project plan expedited the process.”
Diane Bryant
“Excellent communication, diligent work. There is a strong quality background and QMS norms expertise.”
Samip Shah
“Professional and easy to work with! They have been instrumental in getting CE Marking for our products in the quickest way. They created clinical evaluations and risk assessment reports and provided advice on testing and manufacturing.”
Daniel Kinsey
“Highly recommend Elexes! They always meet commitments and follow through on action items.”
Joshua Mink
“Prompt and competent! Elexes should be your next regulatory consultant. Their timeline-based project plan expedited the process.”
Diane Bryant
The Elexes Difference
Why Choose Elexes?
Manufacturers rely on Elexes for precise, practical labeling and regulatory guidance.
Deep Expertise
50+ years of collective experience across medical device regulatory and compliance functions.
Global Coverage
Support spans FDA, EU MDR, TGA, Health Canada, and other major regulatory frameworks.
Submission Focus
Labeling is aligned with technical files, claims, risk documentation, and review expectations.
Proven Results
250+ successful projects and a 90% audit clearance rate demonstrate disciplined execution.
Meet The Elexes Team
Experienced specialists supporting complex regulatory documentation worldwide.
Elexes Medical Consulting Pvt. Ltd. has built its reputation by helping medical device manufacturers navigate complex regulatory pathways with confidence. Over the years, the company has supported organizations across the product lifecycle, from development-stage planning through approvals, launch, and post-market obligations. Its consultants bring deep experience across labeling, technical documentation, quality systems, and global submissions, allowing clients to address compliance issues before they become costly delays. Today, Elexes supports manufacturers across the USA, Europe, Australia, Canada, and other international markets with practical, evidence-based guidance. The team’s focus is simple: deliver clear regulatory direction, strengthen documentation quality, and help clients move toward market access with fewer surprises.
50+ YearsCollective regulatory and quality consulting experience.250+ ProjectsSuccessful regulatory and compliance engagements completed.200+ Product TypesExperience across diverse device categories and technologies.
Frequently Asked Questions
What are the legal requirements for labelling?
Medical device labeling requirements vary by market, but generally include accurate device identification, intended use, manufacturer details, warnings, contraindications, storage conditions, and any mandatory symbols or UDI elements. Labels and IFUs must also be consistent with the technical documentation and approved claims. Regulators expect labeling to be truthful, complete, and supported by evidence, not just commercially appealing.
What are the regulatory requirements of TGA?
For medical devices in Australia, the TGA requires compliance with the Therapeutic Goods Act 1989, the Medical Devices Regulations 2002, and applicable labeling rules such as TGO 91. Requirements typically include ARTG inclusion, conformity assessment evidence, Essential Principles compliance, and market-appropriate labeling and IFUs. Labels prepared for FDA or EU MDR often need targeted review before they are suitable for Australia.
Why is medical device labeling so important in regulatory submissions?
Labeling is one of the first places regulators check for consistency between your claims, intended use, risk controls, and technical documentation. If labels or IFUs contain unsupported statements, omit mandatory content, or conflict with the submission file, they can trigger deficiencies, delays, or broader credibility concerns. Strong labeling helps reinforce the overall compliance story of the device.
What documents are usually included in labeling and information review?
A labeling review commonly covers product labels, outer packaging, Instructions for Use, patient information, symbols, UDI content, promotional claims that may affect regulatory positioning, and cross-references to technical documentation. Depending on the market, reviewers may also assess language requirements, implant cards, electronic labeling considerations, and consistency with risk management, clinical evidence, and submission summaries.
Can one label work for FDA, EU MDR, and TGA at the same time?
A core global label can often be developed, but a single version rarely works unchanged across all markets. FDA, EU MDR, and TGA each have distinct expectations for mandatory statements, symbols, language, UDI presentation, and claim boundaries. The most effective approach is usually a harmonized base label supported by market-specific adaptations that preserve consistency while meeting local requirements.
How do labeling issues delay market approval?
Labeling issues can delay approval by creating inconsistencies that force regulators to question the intended use, safety messaging, or evidence supporting the device. Missing warnings, unclear indications, unsupported performance claims, or incorrect symbols often lead to deficiency letters or requests for clarification. Fixing these late in the process can also require updates to risk files, clinical documents, and submission sections.
Do labeling and IFU reviews include UDI compliance?
Yes, UDI is often a critical part of labeling review. Depending on the target market, the review may assess whether UDI elements are required, correctly formatted, properly placed, and consistent with registration or submission data. UDI compliance also needs to align with packaging levels, device identification records, and any applicable database or authority-specific implementation requirements.
When should manufacturers review labeling during development?
Labeling should be reviewed early enough to influence design outputs, risk controls, usability considerations, and submission planning—not just at the final artwork stage. An early review helps ensure intended use language, warnings, symbols, and user instructions are built into the broader regulatory strategy. A second detailed review is usually valuable before submission, audit, or commercial release.
Still Have Labeling Questions?
Speak with our regulatory specialists about your documentation needs.
Global Service Areas
Elexes supports medical device manufacturers across major regulatory markets with remote, expert-led consulting services.
8+ Markets
Regions Served
100+ Global Clients
Client Reach
Remote Support
Project Delivery
USA
UK
Europe
Canada
Australia
Asia
Need Support In Your Market?
Ask about labeling requirements for your target region.
Certified & Trusted
Awards and Recognition
ISO 13485
Medical device quality system expertise.
MDSAP
Multi-market audit readiness support.
IEC 62304
Software lifecycle compliance knowledge.
